Moody's (MCO) officer sells 2,120 shares at $511.18 – Form 4
Form 4 shows Moody's Analytics President Stephen T. Tulenko executed two open-market sales of MCO common stock on 07/30/2025.
Rhea-AI Filing Summary
Form 4 shows Moody's Analytics President Stephen T. Tulenko executed two open-market sales of MCO common stock on 07/30/2025. The primary trade disposed of 2,120 shares at $511.18 (~$1.08 million in proceeds), while a fractional adjustment of 0.488 shares at $511.87 followed. After these transactions, Tulenko continues to hold 5,558.382 directly owned shares. No derivative activity or 10b5-1 plan indication was disclosed.
Positive
- None.
Negative
- Insider sale: 2,120 shares sold for ~$1.08 M could be perceived as a modest negative signal, though scale is small relative to market cap.
Insights
TL;DR Small insider sale (~$1.1 M) by divisional president; ownership remains sizable—signal is modestly negative but not material.
The reported sale equals roughly 27% of Tulenko’s prior direct holdings, yet absolute size is minor relative to Moody’s $94 B market cap. No 10b5-1 checkbox was marked, so trades appear discretionary. Continued ownership of 5,558 shares suggests ongoing alignment. Overall, the filing provides limited insight into company fundamentals and should not materially alter valuation models.
TL;DR Routine Form 4; discretionary sale by officer, governance risk unchanged.
Insider sales become red flags when clustered or coupled with adverse news. This isolated transaction lacks such context. Tulenko remains an officer in good standing and still holds over $2.8 M in equity (at the sale price), maintaining incentive alignment. Governance posture therefore stays stable.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,120 | $511.18 | $1.08M |
| Sale | Common Stock | 0.488 | $511.87 | $249.79 |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is Tulenko's remaining stake in Moody's after the sale?
Did the filing indicate use of a Rule 10b5-1 trading plan?
Were any derivative securities involved in this Form 4?
Is this insider sale considered material to MCO investors?
AI-generated analysis. How Rhea-AI works. Not financial advice.